• Financials
• Stock Watch
• Earnings Estimate
• Fundamentals
• Trading Statistics *
• Ratios *
• Balance Sheet Highlights *
• Cash Flow Highlights *
• Income Statement Highlights *
• Shareholder Reports
• Webcasts
• Regulatory Filings
• Product Pipeline
• About Biovail
• The Company
• Business Strategy
• Affiliated Companies
• Corporate Governance
• Press Room
• Contact Us
• Investor Contact
• Analysts
• Request Investor Information
• Corporate Fact Sheet

Biovail's Credit Suisse presentation is scheduled for Thursday, November 12, 2009 at 5:00pm MST (7:00pm EST). The Lazard Capital Markets presentation is scheduled for November 18, 2009 at 2:45 pm EST. A live and archived Webcast will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.

SOURCE: Biovail Corporation

Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice President, Investor Relations & Corporate Communications